Cliff Asness AQR Capital Management
Cliff Asness is a co-founder of AQR Capital Management, a leading quantitative investment firm spanning equities, alternatives, and factor strategies. He is known for academic-informed research on value, momentum, and other systematic premia, as well as candid market commentary. Asness’s work bridges academic finance and large-scale institutional portfolio management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Atlassian
TEAM
|
+$905M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$786M |
| 3 |
NVIDIA
NVDA
|
+$736M |
| 4 |
Centene
CNC
|
+$642M |
| 5 |
Apple
AAPL
|
+$451M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Molina Healthcare
MOH
|
+$415M |
| 2 |
Intel
INTC
|
+$329M |
| 3 |
General Motors
GM
|
+$237M |
| 4 |
DoorDash
DASH
|
+$225M |
| 5 |
Intuit
INTU
|
+$187M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.3% |
| 2 | Financials | 15.19% |
| 3 | Healthcare | 12.58% |
| 4 | Consumer Discretionary | 12.42% |
| 5 | Industrials | 12.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1726
Gentherm
THRM
$1.23B
| $3.92M | ﹤0.01% |
107,755
-1,955
| -2% | -$70.4K |
|
1727
ArcBest
ARCB
$3.03B
| $3.91M | ﹤0.01% |
52,671
-6,329
| -11% | -$450K |
|
1728
Annexon
ANNX
$976M
| $3.9M | ﹤0.01% |
776,307
+202,184
| +35% | +$773K |
|
1729
IDT Corp
IDT
$1.73B
| $3.89M | ﹤0.01% |
76,050
+490
| +0.6% | +$24.6K |
|
1730
Lindsay Corp
LNN
$1.16B
| $3.89M | ﹤0.01% |
33,033
+1,010
| +3% | +$122K |
|
1731
Griffon
GFF
$4.59B
| $3.88M | ﹤0.01% |
52,669
-21,899
| -29% | -$1.63M |
|
1732
Clarivate
CLVT
$1.38B
| $3.88M | ﹤0.01% |
1,160,597
+237,834
| +26% | +$846K |
|
1733
National Healthcare
NHC
$3.52B
| $3.87M | ﹤0.01% |
28,249
+1,421
| +5% | +$184K |
|
1734
PROG Holdings
PRG
$1.59B
| $3.87M | ﹤0.01% |
131,301
+52,359
| +66% | +$1.56M |
|
1735
Acadia Healthcare
ACHC
$2.78B
| $3.87M | ﹤0.01% |
272,670
+114,868
| +73% | +$2.17M |
|
1736
ORIX
IX
$42.9B
| $3.86M | ﹤0.01% |
132,107
+28,292
| +27% | +$749K |
|
|
EHAB
1737
DELISTED
Enhabit
EHAB
| $3.86M | ﹤0.01% |
418,293
-26,077
| -6% | -$226K |
|
|
NAGE
1738
Niagen Bioscience
NAGE
$259M
| $3.85M | ﹤0.01% |
605,954
+18,957
| +3% | +$132K |
|
1739
Movado Group
MOV
$777M
| $3.85M | ﹤0.01% |
186,862
+90,578
| +94% | +$1.77M |
|
1740
OFG Bancorp
OFG
$2.2B
| $3.85M | ﹤0.01% |
93,994
-2,202
| -2% | -$90.1K |
|
1741
Cathay General Bancorp
CATY
$4.13B
| $3.85M | ﹤0.01% |
79,523
+9,790
| +14% | +$471K |
|
|
CSGS
1742
DELISTED
CSG Systems International
CSGS
| $3.85M | ﹤0.01% |
50,171
-9,039
| -15% | -$667K |
|
1743
PRA Group
PRAA
$741M
| $3.81M | ﹤0.01% |
215,237
+127,326
| +145% | +$1.98M |
|
1744
HNI Corp
HNI
$3.6B
| $3.8M | ﹤0.01% |
90,508
+22,001
| +32% | +$929K |
|
1745
Sunrun
RUN
$2.21B
| $3.79M | ﹤0.01% |
206,050
+82,791
| +67% | +$1.59M |
|
1746
Saia
SAIA
$9.17B
| $3.79M | ﹤0.01% |
11,596
+6,751
| +139% | +$2.04M |
|
1747
Arvinas
ARVN
$628M
| $3.78M | ﹤0.01% |
318,985
+95,163
| +43% | +$1.04M |
|
1748
Palomar
PLMR
$3.47B
| $3.78M | ﹤0.01% |
28,027
+10,664
| +61% | +$1.3M |
|
1749
Helen of Troy
HELE
$673M
| $3.77M | ﹤0.01% |
177,292
-1,329
| -0.7% | -$27.1K |
|
1750
Stellantis
STLA
$19.8B
| $3.75M | ﹤0.01% |
344,788
+286,008
| +487% | +$3.08M |
|
Similar funds
Cliff Asness's Q4 2025 Portfolio in Review
As of Q4 2025, Cliff Asness held 3,667 positions worth $191B, up 22% from $156B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Cliff Asness deployed $29.9B of net new capital in Q4 2025, opening 211 new positions and adding to 2,098 existing holdings. Its largest new stake was Celestica: 1,066,543 shares worth $315M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 25% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Molina Healthcare, an estimated $415M trimmed.
- Cliff Asness's largest Q4 2025 buy was Celestica: 1,066,543 shares worth $315M.
- Cliff Asness added most to Atlassian in Q4 2025, an estimated $905M increase.
- Cliff Asness's biggest Q4 2025 reduction was Molina Healthcare, cutting an estimated $415M.
- Cliff Asness fully exited Light & Wonder in Q4 2025, selling an estimated $70.7M.
- Cliff Asness's ten largest holdings make up 12% of its $191B portfolio in Q4 2025.
- Cliff Asness opened 211 new positions and closed 105 in Q4 2025.
- Cliff Asness's portfolio value rose 22% quarter-over-quarter to $191B.
Based on AQR Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.